Stockscreener 앱 받기
18.21
7.12%
1.21
시간 외 거래:
17.91
-0.30
-1.65%
전일 마감가:
$17.00
열려 있는:
$16.56
하루 거래량:
37,664
Relative Volume:
0.23
시가총액:
$39.20M
수익:
-
순이익/손실:
$-29.28M
주가수익비율:
-1.3411
EPS:
-13.5784
순현금흐름:
$-27.36M
1주 성능:
-8.72%
1개월 성능:
+12.69%
6개월 성능:
+64.98%
1년 성능:
+5.57%
1일 변동 폭
$16.04
$18.44
1주일 범위
$16.04
$21.02
52주 변동 폭
$6.27
$39.75
Promis Neurosciences Inc Stock (PMN) Company Profile
명칭
Promis Neurosciences Inc
전화
416-847-6898
주소
SUITE 200, 1920 YONGE STREET, TORONTO
Compare PMN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PMN
Promis Neurosciences Inc
|
18.21 | 36.59M | 0 | -29.28M | -27.36M | -13.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Promis Neurosciences Inc 주식(PMN)의 최신 뉴스
ProMIS Neurosciences (PMN) registers 13.83M shares after $75.5M private placement - Stock Titan
Wellington holds 9.99% of ProMIS Neurosciences (NASDAQ: PMN) via shares and warrants - Stock Titan
ALS, Parkinson’s vaccine data to debut at leading AD/PD 2026 meeting - Stock Titan
ProMIS Neurosciences, Inc. (PMN) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Abg V Siv X Ltd Net Worth (2026) - GuruFocus
Abg V Siv Ix Ltd Net Worth (2026) - GuruFocus
Sentiment Recap: Can ProMIS Neurosciences Inc. continue delivering strong returns2026 Earnings Impact & Weekly Chart Analysis and Guides - baoquankhu1.vn
Promis Neurosciences (NASDAQ:PMN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Published on: 2026-03-10 05:13:34 - baoquankhu1.vn
PMN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Trade Report: Can ProMIS Neurosciences Inc continue delivering strong returnsJuly 2025 Fed Impact & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Eugene Williams Increases Stake in ProMIS Neurosciences Inc with Recent Share Purchase - GuruFocus
ProMIS Neurosciences (PMN) director purchases 2,000 common shares in open market - Stock Titan
Published on: 2026-03-05 21:52:27 - baoquankhu1.vn
Eugene Williams Increases Stake in ProMIS Neurosciences Inc - GuruFocus
Promis Neurosciences (NASDAQ:PMN) Director Eugene Williams Buys 2,000 Shares - MarketBeat
Eugene Williams Acquires 1,000 Shares of Promis Neurosciences (NASDAQ:PMN) Stock - MarketBeat
ProMIS Neurosciences, Inc. (PMN.TO) Competitors - Meyka
PMN Stock Price and Chart — NASDAQ:PMN - TradingView
ProMIS Neurosciences : PMN - 24/7 Wall St.
Ally Bridge entities disclose ProMIS (PMN) shares and warrant terms - Stock Titan
PMN PE Ratio & Valuation, Is PMN Overvalued - Intellectia AI
Can ADMA Biologics Inc deliver consistent EPS growthJuly 2025 Breakouts & Short-Term Trading Alerts - baoquankhu1.vn
Insider Buying: Johanne Kaplan Acquires Shares of ProMIS Neurosc - GuruFocus
Insider buy: ProMIS Neurosciences (PMN) CDO acquires 1,629 shares at $15.35 - Stock Titan
Final Results - ADVFN
What to expect from Gossamer Bio’s late-stage lung disease study - statnews.com
ProMIS Neurosciences CEO touts “watershed year” as PMN310 Alzheimer’s Phase 1b data nears - Defense World
Is ProMIS Neurosciences Inc. stock positioned well for digital economyWeekly Trend Recap & Smart Swing Trading Techniques - mfd.ru
Promis Neurosciences (NASDAQ:PMN) Cut to “Strong Sell” at Wall Street Zen - Defense World
PMN Should I Buy - Intellectia AI
SPHERA FUNDS MANAGEMENT LTD. Acquires Additional Shares in ProMIS Neurosciences Inc. - GuruFocus
ProMIS Neurosciences: Phase 1b Alzheimer's trial fully enrolled and financed, with pivotal data expected in 2026 - TradingView
Is ProMIS Neurosciences Inc. (23J0) stock a safe buy pre earningsJobs Report & Weekly Breakout Stock Alerts - mfd.ru
Guggenheim Remains a Buy on ProMIS Neurosciences (PMN) - The Globe and Mail
Insider Stock Purchases: February 06, 2026 - Quiver Quantitative
ProMIS Neurosciences (PMN) Rating Maintained but Price Target Sl - GuruFocus
ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Profit Review: Can ProMIS Neurosciences Inc. continue delivering strong returnsJuly 2025 Trade Ideas & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Promis Neurosciences (NASDAQ:PMN) Short Interest Down 14.8% in January - Defense World
ProMIS Neurosciences, Inc. announced that it expects to receive $75.464029 million in funding from a group of investors - marketscreener.com
ProMIS Neurosciences Announces $75 Million PIPE Financing - The Globe and Mail
ProMIS Neurosciences raises $175 million in PIPE financing By Investing.com - Investing.com South Africa
ProMIS Neurosciences Inc. (PMN) stock: surges 34% after $175M PIPE financing deal - parameter.io
ProMIS Neurosciences Secures $175 Mln In Private Financing - Nasdaq
ProMIS Neurosciences Stock Fluctuates Amid Market Developments - timothysykes.com
ProMIS Neurosciences Signs Multiple Material Agreements - TradingView
ProMIS Neurosciences raises $175 million in PIPE financing - Investing.com
Promis Neurosciences Inc (PMN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):